Sisman, Y.; Vestergaard, L.K.; de Oliveira, D.N.P.; Poulsen, T.S.; Schnack, T.H.; Høgdall, C.; Høgdall, E.
Potential Targeted Therapies in Ovarian Cancer. Pharmaceuticals 2022, 15, 1324.
https://doi.org/10.3390/ph15111324
AMA Style
Sisman Y, Vestergaard LK, de Oliveira DNP, Poulsen TS, Schnack TH, Høgdall C, Høgdall E.
Potential Targeted Therapies in Ovarian Cancer. Pharmaceuticals. 2022; 15(11):1324.
https://doi.org/10.3390/ph15111324
Chicago/Turabian Style
Sisman, Yagmur, Lau Kræsing Vestergaard, Douglas Nogueira Perez de Oliveira, Tim Svenstrup Poulsen, Tine Henrichsen Schnack, Claus Høgdall, and Estrid Høgdall.
2022. "Potential Targeted Therapies in Ovarian Cancer" Pharmaceuticals 15, no. 11: 1324.
https://doi.org/10.3390/ph15111324
APA Style
Sisman, Y., Vestergaard, L. K., de Oliveira, D. N. P., Poulsen, T. S., Schnack, T. H., Høgdall, C., & Høgdall, E.
(2022). Potential Targeted Therapies in Ovarian Cancer. Pharmaceuticals, 15(11), 1324.
https://doi.org/10.3390/ph15111324